On the morning of October 23, 2020, following the opening ceremony of the fourth Psoriasis Congress, renowned psoriasis experts at home and abroad delivered a keynote report on the latest experience in the prevention and treatment of psoriasis, the general situation of psoriasis prevention and treatment, and the scientific research achievements related to the mechanism of psoriasis.

        The first-half conference report was co-chaired by Professor Zheng Jie from The Affiliated Hospital of Shanghai Jiao Tong University and Professor Sun Liangdan from the first Affiliated Hospital of Anhui Medical University.

        Professor Wang Gang, from Xijing Skin Hospital of the Fourth Military Medical University, first introduced the functional defects of regulatory T cells and the mechanism of psoriasis, clarified the effect of IL-17A on the immunosuppression of regulatory T cells in psoriasis, and explained the role of IL-17A in the pathogenesis of psoriasis in detail.

        Professor Xu Jinhua from Huashan Hospital of Fudan University Shared the efficacy evaluation of MTX (methotrexate), a first-line drug for psoriasis, in the treatment of psoriasis, and the monitoring and prevention of toxic and side effects in the process of using MTX, which brought us "Huashan experience" in the clinical use of MTX.

        Zheng Min, a professor from the Second Affiliated Hospital of Zhejiang University School of Medicine, suggested that we should combine transcriptome, proteomics and extracellular vesicle MiRNA research in the process of biologics therapy to find new biomarkers for the individualized treatment of psoriasis. 

        Professor Chen's from central south university xiangya hospital affiliated to share the risk of skin diseases related to immune factors and related targets, from individualized medication and to establish the system of clinical research in skin big data collection standards and innovation, skin disease hospital Internet ecosystem, etc system introduces the achievements of the innovative team.

        The second half report was co-chaired by Professor Chen Xiang and Professor Wang Zaixing from the first Affiliated Hospital of Anhui Medical University.

        Professor Li Yuzhen from the Second Affiliated Hospital of Harbin Medical University first Shared the treatment of biologic agents in special and refractory psoriasis, including the curative effect on scalp psoriasis, nail psoriasis, genital and metatarsal psoriasis, and Shared his own clinical application experience.

        Professor Li Fuqiu from The Second Hospital of Jilin University summarized all the biological agents used in clinical treatment of psoriasis, and put forward his own views on the reasonable selection of biological agents.

        Shanghai first people's hospital affiliated to Shanghai jiaotong university professor hong-lin wang tells the story of RNA virus infection associated with psoriasis research progress, the key cells of small molecule compounds inhibit psoriasis pathogenesis between Th17 cell differentiation and new prospects of mesenchymal stem cells in the treatment of psoriasis, psoriasis basic and clinical research a new research direction.

        Subsequent satellites will be hosted by Professor Yang Rongya from the PLA General Hospital 7th Medical Center.

        First affiliated hospital of anhui medical university professor Sun Liangdan first share the treasurer, especially the single resistance to the resistance in the treatment of type silver plaque psoriasis, psoriatic arthritis, nail psoriasis and psoriasis disease data, at the same time for China's 3 phase of clinical trial data also showed that the treasurer, especially single resistance is more accord with the demand of Chinese patients with psoriasis treatment.

        Psoriasis skin venereology branch of Chinese medical association branch chairman, professor zhang Shared the 2020 annual of dermatology (AAD) in the United States the latest progress on IL - 23 single resistance, IL - 23 single resistance is a core psoriasis pathogenic pathways of upstream regulatory factors, dermatology, anhui medical university institute team through the whole genome found in exon psoriasis susceptibility genes coding variation IL - 23, in order to develop targeted biologics ancient sage sheet resistance, especially in the treatment of psoriasis has showed good efficacy and safety of clinical response rate is higher, significantly improve the quality of life in patients with psoriasis.

        Professor Lu Yan from Jiangsu Provincial People's Hospital Shared the characteristics of rapid efficacy and good safety of Yizizumab in the treatment of psoriasis, and further improved the therapeutic target of psoriasis, reaching PSAI90 or even PASI100, providing a powerful weapon for doctors to cure psoriasis clinically.

        In the academic report meeting in the morning, experts from basic research progress to specific treatment methods, from traditional diagnostic methods to the research and development of emerging drugs such as biological agents, provided delegates a rare academic feast. The rich and colorful reports made by all the speakers were highly praised by the delegates. The conference was in a warm atmosphere with continuous applause. All the participants expressed that their visit was worthwhile and they were full of expectations for the report in the afternoon.

        On the afternoon of 23rd, the special conference of "Basic Research and Clinical Diagnosis and Treatment of Psoriasis" continued, and the top experts in the field of psoriasis from all over the country delivered wonderful speeches on the latest progress in the field of psoriasis. This forum focuses on the frontier, based on the foundation, close to the clinic, covering a wide range, including the sharing of clinical experience in the treatment of psoriasis with new drugs, research on the treatment of psoriasis with biological agents, and introduction to the diagnosis and treatment of children's psoriasis.

        The first-half conference report was co-chaired by Professor Ran Yuping of West China Hospital of Sichuan University and Professor Wang Zaixing of the first Affiliated Hospital of Anhui Medical University.

        As is known to all, psoriasis is a chronic disease that is refractory and easy to relapse. Professor Cui Yong of China-Japan Friendship Hospital offered us a new viewpoint on the treatment of psoriasis skin lesions with new microne starting from the current situation of external use of drugs for psoriasis.

        Professor Chen Kun from the Hospital of Dermatology, Chinese Academy of Medical Sciences explained to us the principles, clinical application, existing problems and solutions of external drugs for psoriasis.

        Hao Fei, professor of the Third Affiliated Hospital of Chongqing Medical University, Shared the possible infection during the application of various biological agents, including hepatitis B, tuberculosis and bacterial infection, and Shared the prevention and control of infection in the biological targeted therapy for psoriasis.

        Professor Ran Yuping from West China Hospital of Sichuan University introduced the skin lesions of psoriasis with different manifestations from clinical, dermatoscopic and pathological aspects, with special emphasis on the skin lesions under dermatoscope.

        Professor Zhang Chunlei from Peking University Third Hospital focused on the potential biomarkers of the treatment of psoriasis biological agents, introduced the genes and cytokines affecting the treatment of psoriasis from the literature, and Shared them with us.

        Based on the development of psoriasis pathogenesis, Professor Shi Yuling of Shanghai Dermatology Hospital (on behalf of Professor Li Xia) introduced the role of keratinocytes, immune cells and cytokines in the pathogenesis of psoriasis, and introduced the research progress of immunological mechanism of psoriasis in detail.

        The second half of the meeting was presided over by Professor Wang Peiguang from the first Affiliated Hospital of Anhui Medical University and Professor Bai Xuewen from the Second Affiliated Hospital of Harbin University of Science and Technology.

        Professor Lai Yuping from East China Normal University explained the pathogenesis of psoriasis from the perspective of keratinocytes regulating the occurrence, development and recurrence of psoriasis.

        Professor Chen Min from the Hospital of Dermatology, Chinese Academy of Medical Sciences gave a lecture on the strategies and thinking of psoriasis maintenance treatment, and explained the reasons of psoriasis maintenance treatment from the perspective of mechanism, so as to achieve the objective of clinical cure of psoriasis.

        Professor Deng Yunhua from Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology explained the standardized medication and management of biological treatment for psoriasis, including screening before treatment, selection of biological treatment, monitoring during treatment, optimization of treatment plan and follow-up at later stage.

        Professor Bai Xuejun from the Second Affiliated Hospital of Harbin Medical University introduced the biological function of IL-17, the pathophysiological role of IL-17 in psoriasis skin lesions, and the role of IL-17 antibody in the treatment of psoriasis, thus comprehensively introducing the role of IL-17 in psoriasis.

        Professor Li Ming from Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine Shared the "Progress in the Diagnosis and treatment of children's pustular psoriasis", and provided a complete plan for the diagnosis and treatment of children's pustular psoriasis from basic to clinical.

        Psoriasis is a kind of skin barrier disease. Professor Li Xia from Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine made a report on "Preventing the recurrence of inflammatory skin diseases by protecting the skin barrier" from the perspective of inflammatory skin barrier.

        Professor Liang Yanhua from Shenzhen Hospital of Southern Medical University presented a report on "A real world Study on biological therapy for Psoriasis - single point analysis of Shenzhen Hospital of Southern Medical University" for the conference.

        At the end of the conference, Professor Yin Zhiqiang of Jiangsu Provincial People's Hospital made a detailed report on the progress of diagnosis and treatment of psoriasis.

        In the academic report meeting in the afternoon, all the experts presented a wonderful academic feast for us. Each speaker started from different angles and comprehensively interpreted the latest research progress of psoriasis. It is believed that this academic conference will further improve the diagnosis and treatment level of clinical dermatologists in China and play a positive role in promoting the development of psoriasis prevention and treatment in China.

        Tomorrow wonderful continue!

        Welcome to WeChat, scan the following qr code and enter our program to watch the live broadcast of the conference!

        Welcome to WeChat scanning qr code to watch the live broadcast of the conference!